Interleukin-3 receptor

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 131.220.35.105 (talk) at 17:27, 2 November 2021 (→‎Possible drug target). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

interleukin 3 receptor, alpha
Identifiers
SymbolIL3RA
Alt. symbolsCD123
HGNC6012
OMIM308385
Other data
LocusChr. X p22.3
interleukin 3 receptor, Y-Chromosomal
Identifiers
SymbolIL3RA
Alt. symbolsIL3RY, IL3RAY
NCBI gene3563
HGNC6012
OMIM430000
Other data
LocusChr. Y p11.3

The interleukin-3 receptor (CD123) is a molecule found on cells which helps transmit the signal of interleukin-3, a soluble cytokine important in the immune system.

The gene coding for the receptor is located in the pseudoautosomal region of the X and Y chromosomes.

The receptor belongs to the type I cytokine receptor family and is a heterodimer with a unique alpha chain paired with the common beta (beta c or CD131) subunit.

The gene for the alpha subunit is 40 kilobases long and has 12 exons.

Cell types and function

The receptor, found on pluripotent progenitor cells, induces tyrosine phosphorylation within the cell and promotes proliferation and differentiation within the hematopoietic cell lines. It can be found on basophils and pDCs as well as some cDCs among peripheral blood mononuclear cells.

CD123 is expressed across acute myeloid leukemia (AML) subtypes, including leukemic stem cells.[1]

Possible drug target

Tagraxofusp, human IL-3 fused to diphteria toxin, is an approved treatment for BPDCN. An experimental antibody-drug conjugate SGN-CD123A targets CD123 as a possible treatment for AML.[1]

References

External links